The deposition of B-sheet fibrils in Alzheimer's disease (AD) brain is widely regarded as the primary cause of this devastating neurodegenerative disease. These deposits include the amyloid-beta (AB) protein in plaques and vascular amyloid and hyper-phosphorylated tau protein in neurofibrillary tangles, dystrophic neurites and neuropil threads. Despite the presence of this characteristic neuropathology and its critical importance in the pathophysiology of the disease, no non-invasive technique exists to assess the presence of these deposits in living patients. The absence of such a technique hinders early and presymptomatic diagnosis and will severely hinder the development of therapies aimed at prevention or reversal of B-sheet fibril deposition. The major theme of the candidate's funded research over the past decade has been the development of small- molecule probes to image B-sheet fibril deposits with non-invasive neuroimaging techniques. The overall goals of this Independent Scientist Award are to obtain training in PET radiochemistry, imaging technology and the neuropathology/neuroanatomy of AD in the context of the final pre-clinical stages of development of these B-sheet probes. The benefits of this training to the candidate's research are numerous. First, by gaining an understanding of radiotracer labeling techniques, the candidate will be better able direct the development of B-sheet fibril imaging probe precursors for radiolabeling. Second, by gaining an understanding of PET imaging technology, data analysis and pertinent neuroradiology, the candidate will be able to participate fully in the translation of the basic medicinal chemistry work already completed in the candidate's laboratory into human studies. Third, by gaining a more detailed understanding of the neuropathology of AD, the candidate will be better able to critically interpret the PET data. The research plan will occur in the setting of and extends currently funded studies aimed at improving the diagnosis and understanding of the pathophysiological progression of AD, including a funded study aimed at developing B-sheet probes for amyloid in AD. The long term goal of the candidate's research is in vivo quantitation of B- sheet fibril deposition in AD to aid in the diagnosis of early and pre- symptomatic AD, to improve the understanding of the pathophysiologic progression of AD and to allow efficacy monitoring of therapies aimed at slowing or halting B-sheet fibril deposition.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Scientist Development Award - Research (K02)
Project #
1K02AG001039-01A1
Application #
6383941
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Buckholtz, Neil
Project Start
2001-09-30
Project End
2006-06-30
Budget Start
2001-09-30
Budget End
2002-06-30
Support Year
1
Fiscal Year
2001
Total Cost
$97,686
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Mathis, Chester A; Kuller, Lewis H; Klunk, William E et al. (2013) In vivo assessment of amyloid-? deposition in nondemented very elderly subjects. Ann Neurol 73:751-61
D'Angelo, Gina M; Weissfeld, Lisa A (2013) Application of copulas to improve covariance estimation for partial least squares. Stat Med 32:685-96
Price, Julie C (2012) Molecular brain imaging in the multimodality era. J Cereb Blood Flow Metab 32:1377-92
Mathis, Chester A; Mason, N Scott; Lopresti, Brian J et al. (2012) Development of positron emission tomography ?-amyloid plaque imaging agents. Semin Nucl Med 42:423-32
Rosario, Bedda L; Weissfeld, Lisa A; Laymon, Charles M et al. (2011) Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. Neuroimage 55:933-41
Wolk, David A; Price, Julie C; Saxton, Judy A et al. (2009) Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 65:557-68
Grimmer, Timo; Riemenschneider, Matthias; Förstl, Hans et al. (2009) Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry 65:927-34
Cohen, Ann D; Price, Julie C; Weissfeld, Lisa A et al. (2009) Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 29:14770-8
Aizenstein, Howard Jay; Nebes, Robert D; Saxton, Judith A et al. (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:1509-17
Klunk, William E (2008) Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist. Arch Neurol 65:1281-3

Showing the most recent 10 out of 20 publications